Onderneming Guangzhou Baiyunshan Pharmaceutical Holding Co., Ltd.
Aandelen
874
CNE100000387
Farmaceutische producten
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
20,65 HKD | 0,00% |
|
-3,50% | -5,06% |
Vakgebied
Aantal werknemers: 28 048
Verkoop per activiteit
HKD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Big Business
70,0
%
| 57 315 | 69,6 % | 58 448 | 70,0 % | +1,98% |
Great Health
14,7
%
| 12 199 | 14,8 % | 12 300 | 14,7 % | +0,83% |
Great Southern Medicine
14,5
%
| 12 242 | 14,9 % | 12 124 | 14,5 % | -0,96% |
Other
0,7
%
| 562 | 0,7 % | 572 | 0,7 % | +1,66% |
Verkoop per regio
HKD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
China
99,5
%
| 82 286 | 100,0 % | 83 064 | 99,5 % | +0,95% |
Other Countries
0,5
%
| 32 | 0,0 % | 380 | 0,5 % | +1.089,00% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Hong Li
CEO | Chief Executive Officer | 57 | 23-06-17 |
Rui Yu Cai
CHM | Chairman | 57 | - |
Chun Bo Zhang
BRD | Director/Board Member | 47 | 01-01-15 |
Chang Hai Wu
BRD | Director/Board Member | 58 | 28-06-10 |
Hao Shan Zheng
PRN | Corporate Officer/Principal | 48 | - |
Jian Xiong Zheng
PRN | Corporate Officer/Principal | 54 | - |
Xue Zhen Huang
SEC | Corporate Secretary | 50 | 26-04-17 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Lung Tak Wong
BRD | Director/Board Member | 76 | 28-06-10 |
Ju Yan Liu
BRD | Director/Board Member | 59 | 01-12-13 |
Hong Li
CEO | Chief Executive Officer | 57 | 23-06-17 |
Chun Bo Zhang
BRD | Director/Board Member | 47 | 01-01-15 |
Rui Yu Cai
CHM | Chairman | 57 | - |
Jin Yuan Cheng
BRD | Director/Board Member | 51 | 13-01-20 |
Ya Jin Chen
BRD | Director/Board Member | 61 | 29-06-20 |
Min Huang
BRD | Director/Board Member | 60 | 29-06-20 |
Hui Dong Jian
BRD | Director/Board Member | 51 | 03-06-21 |
Bao Qing Sun
BRD | Director/Board Member | 53 | 30-05-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 1 405 890 949 | 582 176 011 ( 41,41 %) | 0 | 49,33 % |
Aandeel B | 1 | 219 900 000 | 219 900 000 ( 100,00 %) | 0 |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
30 880 304 | 7.72% | 88 454 778 $ | |
25 992 330 | 1.50% | 20 990 366 $ | |
1 080 000 | 1.00% | 1 293 516 $ |
Bedrijfsgegevens
Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.
No. 45 Sha Mian North Street Liwan District
510130, Guangzhou
+86 20 6628 1218
http://www.gybys.com.cn![Adres Guangzhou Baiyunshan Pharmaceutical Holding Co., Ltd.(874)](https://cdn.zonebourse.com/static/address/6170711.png)
Sector
Verkoop per activiteit
Verkoop per regio
![Consensus](/images/consensus_flch.gif)
Herzieningen van WPA
Kwartaalomzet - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-5,06% | 6,21 mld. | |
+55,19% | 801 mld. | |
+47,26% | 631 mld. | |
-6,09% | 359 mld. | |
+21,92% | 337 mld. | |
+18,40% | 245 mld. | |
+3,64% | 231 mld. | |
+12,98% | 219 mld. | |
+10,86% | 171 mld. | |
-2,78% | 161 mld. |